Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GHRH antagonist active in vivo against human renal adenoarcinoma

July 21, 1997

Lung cancer survival improved with new radiotherapy technique

July 21, 1997

Medeva acquires license to anthracycline derivative for the treatment of bladder cancer

July 21, 1997

GeneMedicine receives quarterly payment from Corange in anticancer gene medicine collaboration

July 21, 1997

Novel inhibitors of geranylgeranylation from Baldacci

July 21, 1997

ICN describes antisense oligonucleotides for IL-8 and/or IL-8R

July 21, 1997

Spotlight on new drugs for cancer

July 21, 1997

Onyx reports on clinical progress of ONYX-015

July 18, 1997

The Liposome Company reacquires TLC-D-99 rights from Pfizer, reports phase III results

July 18, 1997

Japanese approval for Taxol

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...